Article
Effects of recombinant human granulocyte colony-stimulating factor administration on neutrophil phenotype and functions.
Haematologica - 1 Jan 2000
Carulli G
Abstract excerpt
BACKGROUND AND OBJECTIVE: Recombinant human granulocyte colony-stimulating factor (rhG-CSF) is currently used for treatment of various types of neutropenia, treatment of aplastic anemia, mobilization of peripheral blood progenitor cells. However, rhG-CSF is not only a growth factor for the myeloid lineage, but it also acts as a modulator of neutrophil behavior. The aim of the present review article is to examine...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
